Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.
Saved in:
| Title: | Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial. |
|---|---|
| Authors: | Perrin, Steven1 (AUTHOR), Ladha, Shafeeq2 (AUTHOR), Maragakis, Nicholas3 (AUTHOR), Rivner, Michael H.4 (AUTHOR), Katz, Jonathan5 (AUTHOR), Genge, Angela6 (AUTHOR), Olney, Nicholas7 (AUTHOR), Lange, Dale8 (AUTHOR), Heitzman, Daragh9 (AUTHOR), Bodkin, Cynthia10 (AUTHOR), Jawdat, Omar11 (AUTHOR), Goyal, Namita A.12 (AUTHOR), Bornstein, Jeffrey D.13 (AUTHOR), Mak, Carmen1 (AUTHOR), Appel, Stanley H.14 (AUTHOR) sappel@houstonmethodist.org, Paganoni, Sabrina15 (AUTHOR) spaganoni@mgh.harvard.edu |
| Source: | PLoS Medicine. 10/31/2024, Vol. 21 Issue 10, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15491277 |
|---|---|
| DOI: | 10.1371/journal.pmed.1004469 |